This inventor holds 1 USPTO granted patent. Top assignee: Lipideon Biotechnology Ag. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Moritz Werder: Innovator in Hypocholesterolemic Compounds
Introduction
Moritz Werder is a notable inventor based in Bremgarten, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at reducing cholesterol levels.
Latest Patents
Werder holds a patent for hypocholesterolemic compounds, which are described in his invention as novel compounds useful in the treatment and prevention of atherosclerosis. The patent outlines the formula (I) of these compounds and their potential applications in pharmaceutical compositions, either alone or in combination with other active agents.
Career Highlights
Moritz Werder is associated with Lipideon Biotechnology AG, a company focused on innovative solutions in biotechnology. His work has been instrumental in advancing research related to cholesterol management and cardiovascular health.
Collaborations
Throughout his career, Werder has collaborated with esteemed colleagues, including Lisbet Kvaerno and Helmut Hauser. These partnerships have contributed to the development and refinement of his innovative compounds.
Conclusion
Moritz Werder's contributions to the field of hypocholesterolemic compounds highlight his role as a key innovator in pharmaceutical research. His work continues to impact the treatment of cholesterol-related health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile